Last week in GLP1 (2025/09/08)

GLP1.Guide Staff

07 Sep 2025 — 2 min read

Here’s what happened last week in the GLP1 ecosystem:

🌎 World Health Organization (WHO) adds GLP1 to essential medicines list (for diabetes)

🏛️ FDA Creates 'Green List' of GLP-1 Drug Ingredients Approved for Entry in the U.S.

🧑‍⚖️ CVS Caremark gets sued for stopping coverage of GLP1s

📰 GLP-1 Receptor Agonists Linked to Reduced Risk for Developing Uveitis

Go deeper, learn more

Here are our latest deep dives on the recent news and research behind GLP1s:

Most people have heard of Mounjaro, Zepbound, Wegovy, Ozempic and Rybelsus by now. The words “VK2735” or “Orforglipron” mean nothing to most people, though now almost everyone is familiar with GLP1s as a class of drugs (at the very least the effects). There are some obscure GLP1s under development that

Last week in GLP1 (2025/10/13)

We’ve gathered some key stories from the GLP1 ecosystem in the last week you might have missed: 🔎 GLP1 interfering with medical imaging? 💚 More research on GLP1’s benefits for stopping substance & alcohol Abuse 📑 Ketones + GLP1s prevent muscle loss (in mice) 🚨 Semaglutide Withdrawal and it’s effects on Type

Last week in GLP1 (2025/10/06)

We’ve gathered some key stories from the GLP1 ecosystem in the last week you might have missed: 💼 Costco is now selling heavily discounted GLP1s 🦘 Buzz in Australia around GLP1s as a public benefit 💊 Excitement is growing around oral GLP1s 🏫 Harvard doctor doubles down on benefits of GLP1 for inflammation

Last week in GLP1 (2025/09/22)

Here’s what happened last week in the GLP1 ecosystem: 📊 Study: Wegovy pill shows 16.6% weight loss 📢 Eli Lilly says Orforglipron is even better than the Wegovy pill 📺 GLP1s in patch form? Not yet 📑 GLP1s could reduce all-cause mortality by up to 6% by 2045 ❓Bariatric surgery more effective

Last week in GLP1 (2025/09/08)

GLP1.Guide Staff

🌎 World Health Organization (WHO) adds GLP1 to essential medicines list (for diabetes)

🏛️ FDA Creates 'Green List' of GLP-1 Drug Ingredients Approved for Entry in the U.S.

🧑‍⚖️ CVS Caremark gets sued for stopping coverage of GLP1s

📰 GLP-1 Receptor Agonists Linked to Reduced Risk for Developing Uveitis

Go deeper, learn more

Read more

Oral GLP1s you've probably never heard of

Last week in GLP1 (2025/10/13)

Last week in GLP1 (2025/10/06)

Last week in GLP1 (2025/09/22)

🌎 World Health Organization (WHO) adds GLP1 to essential medicines list (for diabetes)

🏛️ FDA Creates 'Green List' of GLP-1 Drug Ingredients Approved for Entry in the U.S.

🧑‍⚖️ CVS Caremark gets sued for stopping coverage of GLP1s📰 GLP-1 Receptor Agonists Linked to Reduced Risk for Developing Uveitis

Go deeper, learn more

Read more

Oral GLP1s you've probably never heard of

Last week in GLP1 (2025/10/13)

Last week in GLP1 (2025/10/06)

Last week in GLP1 (2025/09/22)

🧑‍⚖️ CVS Caremark gets sued for stopping coverage of GLP1s

📰 GLP-1 Receptor Agonists Linked to Reduced Risk for Developing Uveitis